Former Puma Biotech executive gets U.S. prison term for insider trading | Reuters
Puma Biotechnology Inc
Puma Biotechnology (PBYI) Presents At Barclays Global Healthcare Virtual Conference (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology (NASDAQ:PBYI) Announces Earnings Results, Beats Estimates By $0.11 EPS - Opera News
Puma Biotechnology
Puma Biotechnology
Puma Shares Soar 81% Over 2 Days | Los Angeles Business Journal
PUMA BIOTECHNOLOGY: FDA Approves Labeling Supplement for Puma Biotechnology's NERLYNX® (neratinib) for the Extended Adjuvant Treatment of HER2-Positive Early Stage Breast Cancer | FDA Health News
Puma Biotechnology, Inc. Logo Vector - (.SVG + .PNG) - Tukuz.Com
Federal Jury Awards Puma Biotechnology Investors Damages in Securities Class-Action Verdict | Los Angeles Business Journal
European Patent Board Rules in Favour of Puma Biotechnology - IP News Shots
Puma Biotechnology and Pierre Fabre Enter into Exclusive License Agreement to Develop and Commercialize NERLYNX® (neratinib) in Europe | Business Wire
Here's Why Puma Biotechnology Inc (NASDAQ:PBYI) Is Running Up - Market Exclusive
Puma Biotechnology
Where Will Puma Biotechnology Inc (PBYI) Stock Go Next After It Is Lower By 3.91% in a Week?
Puma Biotechnology, Inc. 2020 Q2 - Results - Earnings Call Presentation (NASDAQ:PBYI) | Seeking Alpha
Puma Biotechnology Secures $125 Million Note Purchase by Athyrium Capital | Business Wire
Is Puma Biotechnology a Buy? | The Motley Fool
Puma Biotechnology
Conspiracy Theory: Did Puma Biotech Exec Resign Because of Bad News Ahead? | BioSpace
Is Puma off the cancer M&A list? With Nerlyx marketing deal, some investors think so | FiercePharma
HCW starts Puma Biotechnology at buy; PT $15 | BioTuesdays
Puma Biotechnology - Crunchbase Company Profile & Funding
Puma Biotechnology
Video Puma Biotechnology Soars on Breast Cancer Drug Results - ABC News
Puma Biotechnology - Crunchbase Company Profile & Funding
